Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial

Files in this item

This item appears in the following Collection(s)

Search DSpace



Browse

My Account

Statistics